Clearmind Medicine, Inc. (CMND)
5.74
-0.26
(-4.33%)
USD |
NASDAQ |
Oct 06, 13:23
Clearmind Medicine Free Cash Flow : -6.997M for July 31, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| July 31, 2026 | -6.997M |
| April 30, 2026 | -6.292M |
| January 31, 2026 | -5.597M |
| October 31, 2025 | -4.778M |
| July 31, 2025 | |
| April 30, 2025 | |
| January 31, 2025 | |
| October 31, 2024 | |
| July 31, 2024 | -4.413M |
| April 30, 2024 | -4.747M |
| January 31, 2024 | -4.618M |
| October 31, 2023 | -6.260M |
| July 31, 2023 | -5.702M |
| April 30, 2023 | -4.496M |
| January 31, 2023 | -5.534M |
| October 31, 2022 | -3.841M |
| Date | Value |
|---|---|
| July 31, 2022 | -5.303M |
| April 30, 2022 | -5.423M |
| January 31, 2022 | -3.778M |
| October 31, 2021 | -2.439M |
| July 31, 2021 | -0.9435M |
| April 30, 2021 | -0.6472M |
| January 31, 2021 | -0.2804M |
| October 31, 2020 | -0.2076M |
| July 31, 2020 | -0.1545M |
| April 30, 2020 | -0.1163M |
| January 31, 2020 | -0.0342M |
| October 31, 2019 | -0.0552M |
| July 31, 2019 | -0.1294M |
| April 30, 2019 | -0.1665M |
| January 31, 2019 | -0.1774M |
| October 31, 2018 | -0.1818M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| InMed Pharmaceuticals, Inc. | -8.628M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -61.10M |
| Lexaria Bioscience Corp. | -7.527M |
| Target Group, Inc. (Canada) | -1.168M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.859M |
| Cash from Investing (Quarterly) | -0.7625M |
| Cash from Financing (Quarterly) | 3.136M |
| Free Cash Flow Per Share (Quarterly) | -1.175 |
| Free Cash Flow to Equity (Quarterly) | -3.572M |
| Free Cash Flow to Firm (Quarterly) | -1.854M |
| Free Cash Flow Yield | -242.0% |